|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.620 EUR | -4.38% |
|
-1.13% | -8.07% |
| 01:34pm | Bigben, Capgemini, Danone, GL Events, Soitec... Key Stocks to Watch Today in Paris | |
| 01:14pm | MBWS Signs Exclusive Distribution Agreement for Flor de Caña Rum Brand in France |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 0.22 | 0.6 | 1.61 | 1.83 | 2 | |||||
Return on Total Capital | 0.41 | 0.92 | 2.2 | 2.47 | 2.58 | |||||
Return On Equity % | -6.91 | 5.07 | -0.48 | 4.39 | 4.63 | |||||
Return on Common Equity | -6.96 | 5.08 | -0.49 | 4.39 | 4.63 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 42.35 | 41.13 | 39.11 | 36.41 | 39.05 | |||||
SG&A Margin | 33.61 | 34.73 | 30.18 | 28.81 | 30.18 | |||||
EBITDA Margin % | 3.14 | 4.79 | 6.69 | 6.93 | 7.23 | |||||
EBITA Margin % | 3.44 | 2.7 | 4.83 | 5.22 | 5.9 | |||||
EBIT Margin % | 0.62 | 1.56 | 3.9 | 4.19 | 4.72 | |||||
Income From Continuing Operations Margin % | -3.27 | 3.95 | -0.51 | 4.51 | 5.13 | |||||
Net Income Margin % | -22.75 | 3.34 | -0.52 | 4.5 | 5.12 | |||||
Net Avail. For Common Margin % | -3.28 | 3.95 | -0.52 | 4.5 | 5.12 | |||||
Normalized Net Income Margin | 0.98 | 1.06 | 2.36 | 2.82 | 3.49 | |||||
Levered Free Cash Flow Margin | 2.6 | -9.45 | -2.38 | -2.49 | 3.48 | |||||
Unlevered Free Cash Flow Margin | 3.68 | -9.28 | -2.32 | -2.42 | 3.57 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.57 | 0.62 | 0.66 | 0.7 | 0.68 | |||||
Fixed Assets Turnover | 4.01 | 6.03 | 6.7 | 6.68 | 5.65 | |||||
Receivables Turnover (Average Receivables) | 5.01 | 5.88 | 4.57 | 4.6 | 4.97 | |||||
Inventory Turnover (Average Inventory) | 2.12 | 2.69 | 2.54 | 2.39 | 2.29 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.23 | 2.11 | 2.04 | 2.39 | 2.71 | |||||
Quick Ratio | 0.71 | 1.51 | 1.32 | 1.54 | 1.64 | |||||
Operating Cash Flow to Current Liabilities | 0.04 | -0.14 | -0.13 | 0.03 | 0.29 | |||||
Days Sales Outstanding (Average Receivables) | 73.04 | 62.08 | 79.92 | 79.42 | 73.64 | |||||
Days Outstanding Inventory (Average Inventory) | 172.35 | 135.6 | 143.84 | 152.91 | 159.54 | |||||
Average Days Payable Outstanding | 221.72 | 126.04 | 97.24 | 104.93 | 101.5 | |||||
Cash Conversion Cycle (Average Days) | 23.66 | 71.64 | 126.52 | 127.39 | 131.68 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 129.11 | 3.09 | 3.37 | 3.35 | 3.58 | |||||
Total Debt / Total Capital | 56.35 | 2.99 | 3.26 | 3.24 | 3.46 | |||||
LT Debt/Equity | 98.5 | 1.32 | 1.14 | 1.25 | 1.5 | |||||
Long-Term Debt / Total Capital | 42.99 | 1.28 | 1.1 | 1.21 | 1.44 | |||||
Total Liabilities / Total Assets | 75.35 | 28.8 | 30.05 | 26.2 | 23.42 | |||||
EBIT / Interest Expense | 0.36 | 5.71 | 35.71 | 33.07 | 31.87 | |||||
EBITDA / Interest Expense | 3.66 | 20.28 | 66.39 | 57.58 | 52.1 | |||||
(EBITDA - Capex) / Interest Expense | 1.95 | 13.07 | 50.22 | 36.8 | 27.36 | |||||
Total Debt / EBITDA | 7.97 | 0.65 | 0.5 | 0.48 | 0.53 | |||||
Net Debt / EBITDA | 4.04 | -5.23 | -3.11 | -2.71 | -3.33 | |||||
Total Debt / (EBITDA - Capex) | 14.97 | 1.01 | 0.66 | 0.75 | 1 | |||||
Net Debt / (EBITDA - Capex) | 7.59 | -8.12 | -4.12 | -4.23 | -6.34 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 1.33 | -1.42 | 8.8 | 7.1 | -3 | |||||
Gross Profit, 1 Yr. Growth % | 3.85 | -4.26 | 3.46 | -0.29 | 4.02 | |||||
EBITDA, 1 Yr. Growth % | -260.17 | 50.55 | 51.77 | 10.33 | 17.37 | |||||
EBITA, 1 Yr. Growth % | -352.16 | -22.68 | 94.38 | 15.74 | 9.65 | |||||
EBIT, 1 Yr. Growth % | -114.09 | 147.56 | 172.8 | 15.03 | 9.32 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -81.68 | -219.01 | -114.05 | -1.05T | 10.39 | |||||
Net Income, 1 Yr. Growth % | -41.65 | -114.46 | -116.98 | -1.02T | 10.46 | |||||
Normalized Net Income, 1 Yr. Growth % | -130.23 | 6.52 | 141.11 | 28.13 | 20.16 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -82.99 | -148.16 | -114.08 | -1.02T | 10.26 | |||||
Accounts Receivable, 1 Yr. Growth % | -55.4 | 72.45 | 21.26 | -5.8 | -15.1 | |||||
Inventory, 1 Yr. Growth % | -29.97 | -7.19 | 47.99 | -0.75 | -5.79 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -49.96 | -3.31 | -0.92 | 15.87 | 13.78 | |||||
Total Assets, 1 Yr. Growth % | -17.02 | 1.02 | 2.48 | -1.12 | 1.26 | |||||
Tangible Book Value, 1 Yr. Growth % | 233.31 | -411.5 | 2.86 | 10.15 | 10.77 | |||||
Common Equity, 1 Yr. Growth % | -29.4 | 192.76 | 0.69 | 4.44 | 5.08 | |||||
Cash From Operations, 1 Yr. Growth % | -126.07 | -306.12 | 10.55 | -116.11 | 896.67 | |||||
Capital Expenditures, 1 Yr. Growth % | -44.51 | -34.81 | -2.26 | 59.65 | 35 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -57.65 | -458.7 | -72.54 | 12.09 | -197.59 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -46.98 | -348.45 | -72.84 | 11.73 | -202.54 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -22.4 | -0.06 | 3.56 | 7.95 | 1.92 | |||||
Gross Profit, 2 Yr. CAGR % | -13.1 | -0.29 | -0.47 | 1.57 | 1.84 | |||||
EBITDA, 2 Yr. CAGR % | -54.03 | 55.28 | 51.16 | 29.8 | 5.62 | |||||
EBITA, 2 Yr. CAGR % | -58.4 | 39.63 | 22.6 | 49.99 | 12.65 | |||||
EBIT, 2 Yr. CAGR % | -82.91 | -40.93 | 159.88 | 77.15 | 12.14 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -69.38 | -53.31 | -59.11 | 15.29 | 223.18 | |||||
Net Income, 2 Yr. CAGR % | -21.17 | -70.95 | -84.33 | 25.27 | 219.47 | |||||
Normalized Net Income, 2 Yr. CAGR % | -74.71 | -43.26 | 60.26 | 75.76 | 24.08 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -75.77 | -71.38 | -73.96 | 14.02 | 219.06 | |||||
Accounts Receivable, 2 Yr. CAGR % | -42.02 | -12.3 | 44.61 | 6.88 | -10.57 | |||||
Inventory, 2 Yr. CAGR % | -23.47 | -19.38 | 17.2 | 21.19 | -3.3 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -36.38 | -30.44 | -2.12 | 7.15 | 14.82 | |||||
Total Assets, 2 Yr. CAGR % | -13.54 | -8.44 | 1.75 | 0.66 | 0.06 | |||||
Tangible Book Value, 2 Yr. CAGR % | 308.15 | 222.22 | 79 | 6.44 | 10.46 | |||||
Common Equity, 2 Yr. CAGR % | -19.45 | 43.77 | 71.69 | 2.55 | 4.76 | |||||
Cash From Operations, 2 Yr. CAGR % | -72.23 | -26.7 | 50.95 | -57.8 | 26.7 | |||||
Capital Expenditures, 2 Yr. CAGR % | -52.73 | -39.85 | -20.17 | 24.92 | 46.81 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -72.19 | 23.25 | -0.76 | -44.52 | 23.08 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -65.77 | 14.77 | -17.85 | -44.91 | 26.53 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -25.85 | -15.95 | 2.81 | 4.73 | 4.17 | |||||
Gross Profit, 3 Yr. CAGR % | -17.09 | -10.25 | 0.95 | -0.41 | 2.38 | |||||
EBITDA, 3 Yr. CAGR % | -33.21 | -31.74 | 54.1 | 36.38 | 19.43 | |||||
EBITA, 3 Yr. CAGR % | 140.07 | -48.85 | 55.91 | 20.27 | 35.12 | |||||
EBIT, 3 Yr. CAGR % | -66.08 | -58.35 | -1.63 | 98.06 | 50.82 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -56.54 | -51.85 | -68.72 | 16.52 | 13.63 | |||||
Net Income, 3 Yr. CAGR % | -17.02 | -55.21 | -75.71 | -39 | 20.13 | |||||
Normalized Net Income, 3 Yr. CAGR % | -50.11 | -59.16 | -8.09 | 48.74 | 54.84 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -62.81 | -69.54 | -77.41 | -14.45 | 12.75 | |||||
Accounts Receivable, 3 Yr. CAGR % | -36.52 | -16.62 | -2.3 | 25.36 | -1.01 | |||||
Inventory, 3 Yr. CAGR % | -18.34 | -18.39 | -1.29 | 10.88 | 11.43 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | -25.16 | -26.85 | -21.74 | 3.54 | 9.31 | |||||
Total Assets, 3 Yr. CAGR % | -14.01 | -8.93 | -4.94 | 0.78 | 0.86 | |||||
Tangible Book Value, 3 Yr. CAGR % | -19.58 | 272.99 | 120.22 | 52.25 | 7.87 | |||||
Common Equity, 3 Yr. CAGR % | -25.81 | 23.85 | 27.67 | 45.47 | 3.38 | |||||
Cash From Operations, 3 Yr. CAGR % | -43.58 | -45.83 | -15.94 | -28.4 | 21.07 | |||||
Capital Expenditures, 3 Yr. CAGR % | -39.08 | -47.38 | -29.29 | 0.57 | 28.19 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -4.92 | -34.78 | -25.28 | 3.35 | -25.35 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -10.52 | -33.73 | -29.01 | -8.98 | -24.24 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -17.82 | -17.32 | -15.25 | -7.1 | 2.46 | |||||
Gross Profit, 5 Yr. CAGR % | -14.78 | -15.57 | -10.8 | -5.7 | 1.3 | |||||
EBITDA, 5 Yr. CAGR % | -14.16 | -15.54 | -7.4 | -11.73 | 32.66 | |||||
EBITA, 5 Yr. CAGR % | 1 | -8.5 | 83.48 | -21.34 | 36.91 | |||||
EBIT, 5 Yr. CAGR % | -27.12 | -25.27 | -23.41 | -25.68 | 3.66 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -4.41 | -0.5 | -57.59 | -31.73 | -20.39 | |||||
Net Income, 5 Yr. CAGR % | 45.76 | -4.17 | -57.4 | -32.41 | -31.92 | |||||
Normalized Net Income, 5 Yr. CAGR % | -2.74 | -19.54 | -20.43 | -26.78 | 3.63 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -10.75 | -24.83 | -67.75 | -48.35 | -34.85 | |||||
Accounts Receivable, 5 Yr. CAGR % | -25.46 | -19.03 | -11.76 | -7.91 | -5.69 | |||||
Inventory, 5 Yr. CAGR % | -12.03 | -14.3 | -5.64 | -4.4 | -2.1 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | -11.55 | -15.17 | -16.68 | -14.79 | -8.77 | |||||
Total Assets, 5 Yr. CAGR % | -10.83 | -10.53 | -8.02 | -5.21 | -2.97 | |||||
Tangible Book Value, 5 Yr. CAGR % | -11.1 | 0.99 | 10.76 | 125.87 | 67.1 | |||||
Common Equity, 5 Yr. CAGR % | -19.27 | -3.66 | 3.78 | 14.84 | 17.96 | |||||
Cash From Operations, 5 Yr. CAGR % | -35.66 | -36.29 | -16.36 | -50.98 | -0.95 | |||||
Capital Expenditures, 5 Yr. CAGR % | -13.57 | -29.48 | -32.12 | -25.64 | -5.29 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -39.28 | -12.33 | -3.27 | -38.87 | -8.77 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -35.13 | -11.45 | -13.53 | -38.45 | -10.55 |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















